These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1523 related articles for article (PubMed ID: 24704575)
1. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia. Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575 [TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985 [TBL] [Abstract][Full Text] [Related]
3. Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomes. Mo XD; Kong J; Zhao T; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ Biol Blood Marrow Transplant; 2014 Dec; 20(12):2023-8. PubMed ID: 25196855 [TBL] [Abstract][Full Text] [Related]
5. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation. Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658 [TBL] [Abstract][Full Text] [Related]
6. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia]. Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472 [TBL] [Abstract][Full Text] [Related]
7. Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation? Yoon JH; Kim HJ; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW Biol Blood Marrow Transplant; 2014 Jan; 20(1):80-8. PubMed ID: 24149098 [TBL] [Abstract][Full Text] [Related]
8. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience. Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652 [TBL] [Abstract][Full Text] [Related]
9. Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study. Fang J; Zhang R; Wang H; Hong M; Wu Q; Nie D; You Y; Zhong Z; Li W; Hu Y; Xia L Leuk Res; 2016 Jul; 46():61-8. PubMed ID: 27131062 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia. Zheng C; Zhu X; Tang B; Yao W; Song K; Tong J; Geng L; Liu H; Sun Z Ann Hematol; 2015 Mar; 94(3):473-80. PubMed ID: 25217231 [TBL] [Abstract][Full Text] [Related]
11. Incidence, risk factors and outcome of extramedullary relapse after allogeneic hematopoietic stem cell transplantation in patients with adult acute lymphoblastic leukemia. Yu J; Ge X; Luo Y; Shi J; Tan Y; Lai X; Zhao Y; Ye Y; Zhu Y; Zheng W; Huang H Ann Hematol; 2020 Nov; 99(11):2639-2648. PubMed ID: 32889611 [TBL] [Abstract][Full Text] [Related]
12. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse. Solh M; DeFor TE; Weisdorf DJ; Kaufman DS Biol Blood Marrow Transplant; 2012 Jan; 18(1):106-12. PubMed ID: 21703975 [TBL] [Abstract][Full Text] [Related]
13. Is extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation associated with improved survival? Curley C; Durrant S; Kennedy GA Asia Pac J Clin Oncol; 2013 Sep; 9(3):285-9. PubMed ID: 23418909 [TBL] [Abstract][Full Text] [Related]
14. Outcome Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia Treated with Total Body Irradiation-Free Allogeneic Hematopoietic Stem Cell Transplantation: Comparison of Patients with and Without Central Nervous System Involvement. Hamidieh AA; Monzavi SM; Kaboutari M; Behfar M; Esfandbod M Biol Blood Marrow Transplant; 2017 Dec; 23(12):2110-2117. PubMed ID: 28870778 [TBL] [Abstract][Full Text] [Related]
15. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement. Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856 [TBL] [Abstract][Full Text] [Related]
16. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia]. Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271 [TBL] [Abstract][Full Text] [Related]
17. Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group. Itonaga H; Taguchi J; Fukushima T; Tsushima H; Sato S; Ando K; Sawayama Y; Matsuo E; Yamasaki R; Onimaru Y; Imanishi D; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Honda S; Miyazaki Y Biol Blood Marrow Transplant; 2013 Apr; 19(4):607-15. PubMed ID: 23333533 [TBL] [Abstract][Full Text] [Related]
18. Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus. Chamseddine AN; Willekens C; De Botton S; Bourhis JH Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S129-40. PubMed ID: 26297265 [TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation]. Chen Y; Xu Y; Zhu Y; Fu G; Liu Y; Peng J; Fu B; He Q; Wu D; Li X; Zhao X; Chen F Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):859-64. PubMed ID: 21946205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]